<p>PureTech Health plc (NASDAQ:PRTC - 获取免费报告) 的股价在周一开盘前出现了跳空上涨。该股上一个收盘价为 22.45 美元，但开盘价为 23.06 美元。PureTech Health 的股票最新交易价为 24.00 美元，成交量为 2,101 股。</p>
<p>获取 <strong>PureTech Health</strong> 警报：</p>
<h2>PureTech Health 价格表现</h2>
<p>该股的五十日移动平均价格为 23.20 美元，两百日移动平均价格为 25.86 美元。</p>
<h2>机构资金流入和流出</h2>
<p>一家机构投资者最近在 PureTech Health 股票中建立了新头寸。根据最新提交给证券交易委员会（SEC）的 13F 文件，Birch Hill Investment Advisors LLC 在第二季度购入了 PureTech Health plc (NASDAQ:PRTC - 免费报告) 的新头寸。该公司购入了该公司的 302,000 股股票，价值约为 7,550,000 美元。截至最近一次提交给证券交易委员会（SEC）的文件，Birch Hill Investment Advisors LLC 拥有 PureTech Health 约占公司股份的 1.26%。机构投资者和对冲基金持有该股的 0.04%。</p>
<h2>关于 PureTech Health（获取免费报告）</h2>
<p>PureTech Health plc 在美国从事生物技术和制药解决方案的开发和商业化。该公司正在开发处于第 2 阶段的 LYT-100，用于治疗特发性肺纤维化（IPF）；以及处于第 1/2 阶段的 IgG4 单克隆抗体 LYT-200，针对固体肿瘤和血液恶性肿瘤的靶向葡聚糖结合蛋白-9。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们比 PureTech Health 更喜欢的股票</li>
<li>投资者如何从盘后交易中受益</li>
<li>为大多数投资者最佳的买入持有策略</li>
<li>股票分拆意味着什么？</li>
<li>艾利·莉莉通往下一个万亿市值的道路</li>
<li>通过这些股息王度过衰退</li>
<li>Mobileye Global：CEO 对未来实力押注 1000 万美元</li>
</ul>
<p>_此即时新闻警报由叙事科技生成，并结合了来自 MarketBeat 的财务数据，旨在为读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com。</p>
<p>→ 卡玛拉·哈里斯会拖累市场吗？（来自 Paradigm Press）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MjY2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MjY2"/></p>
<h2>现在是否值得投资 1,000 美元购买 PureTech Health 股票？</h2>
<p>在考虑购买 PureTech Health 股票之前，您需要听到这个消息。</p>
<p>MarketBeat 持续追踪华尔街评级最高且表现最佳的研究分析师以及他们每天向客户推荐的股票。MarketBeat 已确定了五只顶级分析师悄悄告诉客户在更广泛市场注意之前购买的股票... 而 PureTech Health 不在名单上。</p>
<p>尽管 PureTech Health 目前在分析师中有一个 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

PRTC

<p>PureTech Health plc (NASDAQ:PRTC) 股票在周一市场开盘前跳空至 0.45 美元，较上一个收盘价 0.06 美元上涨。该股最新交易价为 0.00 美元，成交量为 2,101 股。Birch Hill Investment Advisors LLC 最近收购了该公司的 302,000 股股票，价值约 55 万美元。PureTech Health 开发生物制药解决方案，目前正在推进两种产品进行临床试验，用于治疗严重健康状况</p>

<p>PureTech Health plc (NASDAQ:PRTC - Get Free Report)'s share price gapped up before the market opened on Monday . The stock had previously closed at $22.45, but opened at $23.06. PureTech Health shares last traded at $24.00, with a volume of 2,101 shares.</p>
<div class="lb-trans"><p>PureTech Health plc (NASDAQ:PRTC - 获取免费报告) 的股价在周一开盘前出现了跳空上涨。该股上一个收盘价为 22.45 美元，但开盘价为 23.06 美元。PureTech Health 的股票最新交易价为 24.00 美元，成交量为 2,101 股。</p>
</div><p>Get <strong>PureTech Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>PureTech Health</strong> 警报：</p>
</div><h2>PureTech Health Price Performance</h2>
<div class="lb-trans"><h2>PureTech Health 价格表现</h2>
</div><p>The stock has a fifty day moving average price of $23.20 and a two-hundred day moving average price of $25.86.</p>
<div class="lb-trans"><p>该股的五十日移动平均价格为 23.20 美元，两百日移动平均价格为 25.86 美元。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>An institutional investor recently bought a new position in PureTech Health stock. Birch Hill Investment Advisors LLC bought a new position in shares of PureTech Health plc (NASDAQ:PRTC - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 302,000 shares of the company's stock, valued at approximately $7,550,000. Birch Hill Investment Advisors LLC owned about 1.26% of PureTech Health as of its most recent filing with the Securities and Exchange Commission (SEC). 0.04% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>一家机构投资者最近在 PureTech Health 股票中建立了新头寸。根据最新提交给证券交易委员会（SEC）的 13F 文件，Birch Hill Investment Advisors LLC 在第二季度购入了 PureTech Health plc (NASDAQ:PRTC - 免费报告) 的新头寸。该公司购入了该公司的 302,000 股股票，价值约为 7,550,000 美元。截至最近一次提交给证券交易委员会（SEC）的文件，Birch Hill Investment Advisors LLC 拥有 PureTech Health 约占公司股份的 1.26%。机构投资者和对冲基金持有该股的 0.04%。</p>
</div><h2>About PureTech Health (Get Free Report)</h2>
<div class="lb-trans"><h2>关于 PureTech Health（获取免费报告）</h2>
</div><p>PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.</p>
<div class="lb-trans"><p>PureTech Health plc 在美国从事生物技术和制药解决方案的开发和商业化。该公司正在开发处于第 2 阶段的 LYT-100，用于治疗特发性肺纤维化（IPF）；以及处于第 1/2 阶段的 IgG4 单克隆抗体 LYT-200，针对固体肿瘤和血液恶性肿瘤的靶向葡聚糖结合蛋白-9。</p>
</div><h2>Recommended Stories</h2>
<ul>
<li>Five stocks we like better than PureTech Health</li>
<li>How Can Investors Benefit From After-Hours Trading</li>
<li>Why the Buy-and-Hold Strategy May Be Best for Most Investors</li>
<li>What Does a Stock Split Mean?</li>
<li>Eli Lilly’s Path to the Next Trillion Market Capitalization</li>
<li>Ride Out The Recession With These Dividend Kings</li>
<li>Mobileye Global: CEO Makes $10 Million Bet on Future Strength</li>
</ul>
<div class="lb-trans"><h2>推荐故事</h2>
<ul>
<li>五只我们比 PureTech Health 更喜欢的股票</li>
<li>投资者如何从盘后交易中受益</li>
<li>为大多数投资者最佳的买入持有策略</li>
<li>股票分拆意味着什么？</li>
<li>艾利·莉莉通往下一个万亿市值的道路</li>
<li>通过这些股息王度过衰退</li>
<li>Mobileye Global：CEO 对未来实力押注 1000 万美元</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p>_此即时新闻警报由叙事科技生成，并结合了来自 MarketBeat 的财务数据，旨在为读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com。</p>
</div><p>→ Kamala Harris To Tank the Market? (From Paradigm Press)(Ad)</p>
<div class="lb-trans"><p>→ 卡玛拉·哈里斯会拖累市场吗？（来自 Paradigm Press）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MjY2" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9266&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in PureTech Health right now?</h2>
<div class="lb-trans"><h2>现在是否值得投资 1,000 美元购买 PureTech Health 股票？</h2>
</div><p>Before you consider PureTech Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑购买 PureTech Health 股票之前，您需要听到这个消息。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 持续追踪华尔街评级最高且表现最佳的研究分析师以及他们每天向客户推荐的股票。MarketBeat 已确定了五只顶级分析师悄悄告诉客户在更广泛市场注意之前购买的股票... 而 PureTech Health 不在名单上。</p>
</div><p>While PureTech Health currently has a &#34;hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管 PureTech Health 目前在分析师中有一个 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

PureTech Health（纳斯达克代码：PRTC）股价跳空上涨至 22.45 美元